Metastatic tumor antigen in hepatocellular carcinoma: golden roads toward personalized medicine
Authors:
- 18 October 2014
- journal article
- review article
- Published by Springer Nature in Cancer and Metastasis Reviews
- Vol. 33 (4) , 965-980
Abstract
Hepatocellular carcinoma (HCC), a prototype of hypervascular tumors, is one of the most common malignancies in the world, especially hyperendemic in the Far East where chronic hepatitis B virus (HBV) infection is highly prevalent. It is characterized by the clinical feature of a poor prognosis or a high mortality due to its already far advanced stages at diagnosis. It is so multifactorial that hepatocarcinogenesis cannot be explained by a single molecular mechanism. To date, a number of pathways have been known to contribute to the development, growth, angiogenesis, and even metastasis of HCC. Among the various factors, metastatic tumor antigens (MTAs) or metastasis-associated proteins have been vigorously investigated as an intriguing target in the field of hepatocarcinogenesis. According to recent studies including ours, MTAs are not only involved in the HCC development and growth (molecular carcinogenesis), but also closely associated with the post-operative recurrence and a poor prognosis or a worse response to post-operative anti-cancer therapy (clinical significance). Herein, we review MTAs in light of their essential structure, functions, and molecular mechanism in hepatocarcinogenesis. We will also focus in detail on the interaction between hepatitis B x protein (HBx) of HBV and MTA in order to clarify the HBV-associated HCC development. Finally, we will discuss the prognostic significance and clinical application of MTA in HCC. We believe that this review will help clinicians to understand the meaning and use of the detection of MTA in order to more effectively manage their HCC patients.Keywords
This publication has 136 references indexed in Scilit:
- Epigenetic control of metastasis-associated protein 1 gene expression by hepatitis B virus X protein during hepatocarcinogenesisOncogenesis, 2012
- Regulation of endothelial cell plasticity by TGF-βCell and tissue research, 2011
- The metastasis-associated protein-1 gene encodes a host permissive factor for schistosomiasis, a leading global cause of inflammation and cancerHepatology, 2011
- TGF-β1 signaling targets metastasis-associated protein 1, a new effector in epithelial cellsOncogene, 2011
- Conversion of vascular endothelial cells into multipotent stem-like cellsNature Medicine, 2010
- NF-κB signaling mediates the induction of MTA1 by hepatitis B virus transactivator protein HBxOncogene, 2009
- E3 ubiquitin ligase COP1 regulates the stability and functions of MTA1Proceedings of the National Academy of Sciences, 2009
- Hepatocyte growth factor induces cell scattering through MAPK/Egr‐1‐mediated upregulation of SnailThe EMBO Journal, 2006
- The transcription factor Snail is a repressor of E-cadherin gene expression in epithelial tumour cellsNature Cell Biology, 2000
- Nucleosome disruption and enhancement of activator binding by a human SW1/SNF complexNature, 1994